FTC Cracks Down on Forever Living Following Years of Deception
Settlement comes after TINA.org exposed thousands of deceptive income claims.
Heermann et al. v. Alchemee, LLC et al.
24-cv-7550, W.D. Mo.
(March 2024)
Howard et al. v. Alchemee, LLC and Taro Pharmaceutical USA, Inc.
24-cv-1834, C.D. Cal.
(March 2024)
Judt et al. v. Alchemee, LLC and Taro Pharmaceuticals U.S.A., Inc.
24-cv-2718, S.D.N.Y.
(April 2024)
O’Dea et al. v. Alchemee, LLC and Taro Pharmaceuticals U.S.A., Inc.
24-cv-2755, N.D. Ill.
(April 2024)
Ramos et al. v. Alchemee, LLC
24-cv-2230, N.D. Cal.
(March 2024)
Teron et al. v. Alchemee, LLC and Taro Pharmaceuticals U.S.A., Inc.
24-cv-7538, N.D. Cal.
(March 2024)
Proactiv
Misleadingly representing that products were safe when they contained, or were at risk of containing, the carcinogen benzene
Heermann case: Pending
Howard cases: Dismissed
Judt case: Voluntarily dismissed When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.
O’Dea case: Pending
Ramos case: Pending
Teron case: Pending
Settlement comes after TINA.org exposed thousands of deceptive income claims.
TINA.org sheds light on confusing and misleading brightness claims.
Company becomes the latest to leave the industry.
The FTC’s Negative Option Rule do-over – and what’s at stake.
Thee incredible almost true story about how Megan Thee Stallion got her pickle back.